Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.
Henry Schein, Inc. reports developments across its health care distribution, practice solutions, and dental technology businesses. The company serves office-based dental and medical practitioners, dental laboratories, government and institutional health care clinics, and other alternate care sites through business, clinical, technology, and supply chain solutions.
Recurring news themes include earnings releases, financial guidance, investor conference participation, board and executive governance updates, and product announcements from Henry Schein One. Recent technology coverage centers on Dentrix Ascend, a cloud-based dental platform that integrates practice management, clinical workflows, imaging, revenue cycle management, analytics, patient experience tools, and AI-enabled workflow capabilities.
Henry Schein, Inc. (Nasdaq: HSIC), a leading provider of health care solutions, presented at the William Blair Emerging Technologies in Dental Care Virtual Investor Conference on May 17, 2022. A replay will be accessible on their investor presentations webpage starting May 19, 2022, for up to two weeks. The company reported sales of $12.4 billion in 2021, with a 12.5% compound annual growth rate since going public in 1995. Henry Schein serves over 1 million customers globally through a network of nearly 22,000 Team Schein Members.
Henry Schein, the largest provider of healthcare solutions for dental and medical practitioners, announced its participation in two upcoming investor conferences in June 2022. The events include the Stifel 2022 Annual Dental & Veterinary Conference on June 1 and the Jefferies 2022 Healthcare Conference on June 9. Live webcasts of the presentations will be available on Henry Schein's investor relations website. The company highlights its extensive global network, serving over 1 million customers with more than 300 solutions aimed at enhancing operational success and clinical outcomes.
Henry Schein has appointed Dirk Benson as Vice President and Chief Commercial Officer of its North America Distribution Group. His role will focus on driving the 'One Distribution' strategy to enhance efficiency and customer experience. Nancy Lanni has been named Vice President and General Manager of the new Strategic Account Management Team. Both executives bring extensive expertise from the health care industry and will play a key role in implementing the company's 2022-2024 BOLD+1 Strategic Plan.
Henry Schein (NASDAQ: HSIC) announced a donation of $200,000 in health care products to Howard University College of Dentistry and Meharry Medical College School of Dentistry. This donation aims to support free oral health care for underserved communities through student outreach programs. During his commencement address, Stanley M. Bergman, CEO, emphasized the importance of health equity. Each graduate of Howard will also receive $1,000 in health care products for charitable care. The company will extend its partnership with Howard University for another four years.
Henry Schein, Inc. (Nasdaq: HSIC), a leading health care solutions provider, will present at the UBS Global Healthcare Conference on May 24, 2022, at 2:00 p.m. Eastern time. The presentation will be available via live webcast on their website, with a replay accessible afterward.
Henry Schein serves over 1 million customers globally with a wide range of solutions, achieving $12.4 billion in sales in 2021. The company operates a centralized distribution network and provides more than 120,000 branded products.
Henry Schein reported record first-quarter 2022 net sales of $3.2 billion, an 8.7% increase from Q1 2021. The GAAP diluted EPS rose to $1.30, up from $1.16 the previous year. The company affirms its full-year 2022 GAAP diluted EPS guidance of $4.75 to $4.91, projecting growth of 7% to 10% over 2021. Growth was driven by strong sales in both the dental and medical segments, particularly in equipment and technology sales. However, sales of COVID-19 related products are expected to decline, impacting overall sales guidance.
Henry Schein (NASDAQ: HSIC) supports the Carry The Load Memorial May campaign, honoring military, veterans, first responders, and their families. The initiative, running from April 28, 2022, involves events such as the Dallas Memorial March and other rallies across the U.S. Team Schein Members will participate in walks, fundraise, and attend educational events. This partnership aligns with Henry Schein's commitment to veterans' health and accessibility to dental care, showcasing its corporate social responsibility through meaningful community engagement.
Summary not available.
Henry Schein, a leading provider of health care solutions, will release its Q1 2022 financial results on May 3, 2022, before market opening. The live webcast of the earnings call starts at 10:00 a.m. Eastern time on the same day. Key speakers include Stanley M. Bergman and Ronald N. South, the new CFO. Investors can access the call via www.henryschein.com/IRwebcasts. Henry Schein, headquartered in Melville, N.Y., operates in 32 countries and reported sales of $12.4 billion in 2021.
Henry Schein, the leading provider of healthcare solutions, announced the retirement of Gerald A. Benjamin as Chief Administrative Officer, effective July 1, 2022. He has served the company for 34 years and will remain an adviser post-retirement. Michael S. Ettinger will be promoted to Chief Operating Officer on the same date, taking on expanded responsibilities. His extensive experience at Henry Schein since 1994 positions him well for this leadership transition. This change marks the implementation of a long-planned succession strategy within the company.